Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

Fda Overhaul Ahead?


Washington Outlook: CAPITAL WRAPUP

FDA OVERHAUL AHEAD?

Republicans and industries clamoring for regulatory easing at the Food & Drug Administration have an unexpected ally. Representative Ron Wyden (D-Ore.), a hero of consumer advocates, has embraced key changes. He favors less pre-approval product testing, fewer export restrictions on unapproved medical devices, and shifting some FDA reviews to outside testing labs. Many Democrats and consumer groups fear such moves could lessen food and medical safety.EDITED BY OWEN ULLMANN


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus